← BACK TO NEWS
13/02/2020

Exclusivity Contract with Biolab for Dapaconazole

We proudly announce that Triquim has been chosen by Biolab as its strategic partner for the manufacture of Dapaconazole.

BIOLAB SANUS FARMACEUTICA, one of the top five Brazilian laboratories, developed and internationally patented its DAPACONAZOLE molecule. For the exclusive manufacture of this innovative molecule, BIOLAB SANUS FARMACEUTICA has chosen TRIQUIM S.A., a state-of-the-art pharmaceutical plant with national and international certifications, serving the global market. The contract between the parties was signed last week in São Paulo, Brazil, strengthening a relationship spanning over four decades.
Exclusivity Contract with Biolab for Dapaconazole

Other News

International Certification NNGYK

TRIQUIM obtained international GMP certification from the National Centre for Public Health and Pharmacy for Hungary (NNGYK)

International Certification NNGYK

We are proud to announce that we have obtained international GMP certification from the National Centre for Public Health and Pharmacy (NNGYK) for Hungary. This recognition reflects our commitment to...

VIEW MORE
President of Aché Visits Triquim

We had the honor of receiving a visit from such a renowned company.

President of Aché Visits Triquim

We were delighted to receive the visit of Ms. Vânia Nogueira de Alcantara Machado, President of Aché, along with Directors from the Technical, R&D, Operations, and New Business areas of...

VIEW MORE
Triquim at Vector Pharma 2019

Vector Pharma is a commercial event that brings together hundreds of companies from the international pharmaceutical industry.

Triquim at Vector Pharma 2019

Triquim participated in Vector Pharma 2019, a major international business forum held in Mexico City in June 2019, where we held one-on-one business meetings with many pharmaceutical industry clients. As...

VIEW MORE

CERTIFICATIONS